A Phase II Study of Blinatumomab in Richter Transformation
Phase of Trial: Phase II
Latest Information Update: 15 Feb 2018
At a glance
- Drugs Blinatumomab (Primary) ; Dexamethasone; Dexamethasone
- Indications Diffuse large B cell lymphoma
- Focus Therapeutic Use
- 09 Feb 2018 Planned End Date changed from 1 Jun 2020 to 1 Jun 2021.
- 22 Jun 2017 Status changed from not yet recruiting to recruiting.
- 25 Apr 2017 New trial record